Searching for your content…
Phone
877-269-7890 from 8 AM – 10 PM ET
Contact Cision
877-269-7890
from 8 AM – 10 PM ET
News provided by
Oct 31, 2022, 07:00 ET
Share this article
 VANCOUVER, BC, Oct. 31, 2022 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.
Dr. Reid Robison, MD MBA, Chief Clinical Officer of Numinus, will participate in the panel Neurobiological Mechanism Difference Between Classic Psychedelics and Ketamine on Saturday, November 5^th at 9:50 a.m. ET.
For more information about the conference, or to schedule a one-on-one meeting with Numinus’ management, please send an email to KCSA Strategic Communications [email protected].
Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect” and “intend” and statements that an event “may”, “will”, “should”, “could” or “might” occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management’s estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
SOURCE Numinus Wellness Inc.
For further information: Investor Contact: Jamie Kokoska, Vice President, Investor Relations & Communications, [email protected]; Media Contact: May Lee, Communications Manager, [email protected]
Also from this source
Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022
877-269-7890
from 8 AM – 10 PM ET

source